Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

DPepH3, an Improved Peptide Shuttle for Receptor-independent Transport across the Blood-Brain Barrier.

Cavaco MC, Garcia JV, da Silva RDM, Correia JDG, Castanho MARB, Andreu Martinez D, Neves VLS.

Curr Pharm Des. 2020 Feb 12. doi: 10.2174/1381612826666200213094556. [Epub ahead of print]

PMID:
32053069
2.

Antibodies for the Treatment of Brain Metastases, a Dream or a Reality?

Cavaco M, Gaspar D, Arb Castanho M, Neves V.

Pharmaceutics. 2020 Jan 13;12(1). pii: E62. doi: 10.3390/pharmaceutics12010062. Review.

3.

Eliciting Negative Affects Using Film Clips and Real-Life Methods.

Cabral JCC, Tavares PS, Weydmann GJ, das Neves VT, de Almeida RMM.

Psychol Rep. 2018 Jun;121(3):527-547. doi: 10.1177/0033294117730844. Epub 2017 Sep 20.

PMID:
29298555
4.

Peptibodies: An elegant solution for a long-standing problem.

Cavaco M, Castanho MARB, Neves V.

Biopolymers. 2017 Dec 21. doi: 10.1002/bip.23095. [Epub ahead of print] Review.

PMID:
29266205
5.

A New Noncanonical Anionic Peptide That Translocates a Cellular Blood-Brain Barrier Model.

Neves-Coelho S, Eleutério RP, Enguita FJ, Neves V, Castanho MARB.

Molecules. 2017 Oct 18;22(10). pii: E1753. doi: 10.3390/molecules22101753.

6.

Novel Peptides Derived from Dengue Virus Capsid Protein Translocate Reversibly the Blood-Brain Barrier through a Receptor-Free Mechanism.

Neves V, Aires-da-Silva F, Morais M, Gano L, Ribeiro E, Pinto A, Aguiar S, Gaspar D, Fernandes C, Correia JDG, Castanho MARB.

ACS Chem Biol. 2017 May 19;12(5):1257-1268. doi: 10.1021/acschembio.7b00087. Epub 2017 Mar 21.

PMID:
28263555
7.

Stress and Cognitive Reserve as independent factors of neuropsychological performance in healthy elderly.

Cabral JC, Veleda GW, Mazzoleni M, Colares EP, Neiva-Silva L, Neves VT.

Cien Saude Colet. 2016 Nov;21(11):3499-3508. doi: 10.1590/1413-812320152111.17452015.

8.

Platform technology to deliver prophylactic molecules orally: an example using the Class A select agent Yersinia pestis.

del Rio B, Fuente JL, Neves V, Dattwyler R, Seegers JF, Gomes-Solecki M.

Vaccine. 2010 Sep 24;28(41):6714-22. doi: 10.1016/j.vaccine.2010.07.084. Epub 2010 Aug 8.

9.

Higher dispersion efficacy of functionalized carbon nanotubes in chemical and biological environments.

Heister E, Lamprecht C, Neves V, Tîlmaciu C, Datas L, Flahaut E, Soula B, Hinterdorfer P, Coley HM, Silva SR, McFadden J.

ACS Nano. 2010 May 25;4(5):2615-26. doi: 10.1021/nn100069k.

PMID:
20380453
10.

Comprehensive seroprofiling of sixteen B. burgdorferi OspC: implications for Lyme disease diagnostics design.

Ivanova L, Christova I, Neves V, Aroso M, Meirelles L, Brisson D, Gomes-Solecki M.

Clin Immunol. 2009 Sep;132(3):393-400. doi: 10.1016/j.clim.2009.05.017. Epub 2009 Jul 2.

11.

Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with Lyme disease.

del Rio B, Dattwyler RJ, Aroso M, Neves V, Meirelles L, Seegers JF, Gomes-Solecki M.

Clin Vaccine Immunol. 2008 Sep;15(9):1429-35. doi: 10.1128/CVI.00169-08. Epub 2008 Jul 16.

12.

Using epidemiological survey data to infer geographic distributions of leishmaniasis vector species.

Peterson AT, Pereira RS, Neves VF.

Rev Soc Bras Med Trop. 2004 Jan-Feb;37(1):10-4. Epub 2004 Mar 19.

Supplemental Content

Loading ...
Support Center